Meade Haller
Meade Haller has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
Yan Yin
Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, United States of America
3 shared publicationsDolores J. Lamb
Center for Reproductive Medicine, Department of Molecular and Cellular Biology and Scott Department of Urology, Baylor College of Medicine, TX 77030, USA
2 shared publicationsLiang Ma
Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, United States of America
2 shared publications- Liang Ma
Division of Dermatology, Washington University School of Medicine , St. Louis, MO 63110, USA
2 shared publications Tian Li
Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
2 shared publications- Aakash Patel
University of California, Los Angeles
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
Retinoic acid receptor signaling orchestrates uterine receptivity, decidual competence, and immune homeostasis during early pregnancy
Successful implantation requires precise coordination of uterine epithelial receptivity, stromal decidualization, and immune homeostasis during a narrow peri-implantation window. Although retinoic acid (RA) signaling has been implicated in female reproduction, the endogenous and isoform-specific roles of retinoic acid receptors (RARs) remain poorly defined. Here, we combined isoform-specific genetic mouse models, transcriptomic profiling, and functional studies in mouse and human stromal cells to determine how RAR signaling regulates early pregnancy. We found that RARG is the dominant RAR isoform required for female fertility in mice, as its deletion severely impaired implantation, whereas combined loss of all RAR isoforms caused complete reproductive failure. RAR deficiency disrupted multiple sequential reproductive processes, including sperm transport and fertilization, suppression of uterine estrogen receptor activity, acquisition of stromal decidualization competence, and maintenance of uterine immune homeostasis. Transcriptomic analyses identified conserved epithelial and mesenchymal programs altered across independent RAR-deficient mouse models and revealed significant overlap with endometrial gene signatures from women with recurrent implantation failure. In human endometrial stromal cells, suppression of the RARA isoform consistently disrupted decidualization across three independent primary cell lines and an immortalized cell model. Together, these findings identify RAR signaling as a critical regulator of early pregnancy and reveal conserved, isoform-specific functions required for early pregnancy.
- 10 September 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
Open AccessRetinoic acid receptor signaling orchestrates uterine receptivity, decidual competence, and immune homeostasis during early pregnancy
Successful implantation requires precise coordination of uterine epithelial receptivity, stromal decidualization, and immune homeostasis during a narrow peri-implantation window. Although retinoic acid (RA) signaling has been implicated in female reproduction, the endogenous and isoform-specific roles of retinoic acid receptors (RARs) remain poorly defined. Here, we combined isoform-specific genetic mouse models, transcriptomic profiling, and functional studies in mouse and human stromal cells to determine how RAR signaling regulates early pregnancy. We found that RARG is the dominant RAR isoform required for female fertility in mice, as its deletion severely impaired implantation, whereas combined loss of all RAR isoforms caused complete reproductive failure. RAR deficiency disrupted multiple sequential reproductive processes, including sperm transport and fertilization, suppression of uterine estrogen receptor activity, acquisition of stromal decidualization competence, and maintenance of uterine immune homeostasis. Transcriptomic analyses identified conserved epithelial and mesenchymal programs altered across independent RAR-deficient mouse models and revealed significant overlap with endometrial gene signatures from women with recurrent implantation failure. In human endometrial stromal cells, suppression of the RARA isoform consistently disrupted decidualization across three independent primary cell lines and an immortalized cell model. Together, these findings identify RAR signaling as a critical regulator of early pregnancy and reveal conserved, isoform-specific functions required for early pregnancy.
- 1 October 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (11)
SALL1 Is an Orchestrator of Uterine Receptivity in Part via Titration of Estrogen Signaling
SALL1 is a critical regulator of embryonic development across a wide swath of tissues, including vital organs, but little is known about its function in adult tissues. Recent work from our group demonstrates that SALL1 is involved in urogenital development. This study delineates the role of SALL1 transcription factor in the adult reproductive system by demonstrating its requirement at multiple levels of uterine function during the implantation phase of early pregnancy. By generating a conditional knockout mouse model of Sall1 exclusively in female reproductive organs, it is demonstrated here that SALL1 is independently required both in the uterine luminal epithelium for the attachment of competent blastocysts to the uterine wall and in the uterine stroma for the process of decidualization, another prerequisite for pregnancy success. This robust, multitissue-layer requirement for SALL1 across multiple stages in the process of implantation makes it a newly identified regulator of early pregnancy. Here, it is shown that loss of SALL1 causes misexpression of estrogen receptor α during the window of implantation, and subsequent pathological deregulation of multiple estrogen response genes whose tight titrations are prerequisites of pregnancy. RNA sequencing of independent knockout uterine compartments at multiple timepoints, and chromatin immunoprecipitation sequencing to identify direct transcriptional targets, elucidated multiple powerful regulatory pathways downstream of SALL1. Importantly, the use of a selective estrogen receptor antagonist, fulvestrant, at a precise timepoint and dose, offers a partial rescue of embryo attachment to the uterine luminal epithelium, further demonstrating that SALL1 is upstream of estrogen receptor α during implantation phase signaling.
- 1 October 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (11)
SALL1 Is an Orchestrator of Uterine Receptivity in Part via Titration of Estrogen Signaling
SALL1 is a critical regulator of embryonic development across a wide swath of tissues, including vital organs, but little is known about its function in adult tissues. Recent work from our group demonstrates that SALL1 is involved in urogenital development. This study delineates the role of SALL1 transcription factor in the adult reproductive system by demonstrating its requirement at multiple levels of uterine function during the implantation phase of early pregnancy. By generating a conditional knockout mouse model of Sall1 exclusively in female reproductive organs, it is demonstrated here that SALL1 is independently required both in the uterine luminal epithelium for the attachment of competent blastocysts to the uterine wall and in the uterine stroma for the process of decidualization, another prerequisite for pregnancy success. This robust, multitissue-layer requirement for SALL1 across multiple stages in the process of implantation makes it a newly identified regulator of early pregnancy. Here, it is shown that loss of SALL1 causes misexpression of estrogen receptor α during the window of implantation, and subsequent pathological deregulation of multiple estrogen response genes whose tight titrations are prerequisites of pregnancy. RNA sequencing of independent knockout uterine compartments at multiple timepoints, and chromatin immunoprecipitation sequencing to identify direct transcriptional targets, elucidated multiple powerful regulatory pathways downstream of SALL1. Importantly, the use of a selective estrogen receptor antagonist, fulvestrant, at a precise timepoint and dose, offers a partial rescue of embryo attachment to the uterine luminal epithelium, further demonstrating that SALL1 is upstream of estrogen receptor α during implantation phase signaling.
- 3 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6695) , 584-590
Risk of meningomyelocele mediated by the common 22q11.2 deletion
Meningomyelocele is one of the most severe forms of neural tube defects (NTDs) and the most frequent structural birth defect of the central nervous system. We assembled the Spina Bifida Sequencing Consortium to identify causes. Exome and genome sequencing of 715 parent-offspring trios identified six patients with chromosomal 22q11.2 deletions, suggesting a 23-fold increased risk compared with the general population. Furthermore, analysis of a separate 22q11.2 deletion cohort suggested a 12- to 15-fold increased NTD risk of meningomyelocele. The loss of Crkl , one of several neural tube–expressed genes within the minimal deletion interval, was sufficient to replicate NTDs in mice, where both penetrance and expressivity were exacerbated by maternal folate deficiency. Thus, the common 22q11.2 deletion confers substantial meningomyelocele risk, which is partially alleviated by folate supplementation.
- 3 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6695) , 584-590
Risk of meningomyelocele mediated by the common 22q11.2 deletion
Meningomyelocele is one of the most severe forms of neural tube defects (NTDs) and the most frequent structural birth defect of the central nervous system. We assembled the Spina Bifida Sequencing Consortium to identify causes. Exome and genome sequencing of 715 parent-offspring trios identified six patients with chromosomal 22q11.2 deletions, suggesting a 23-fold increased risk compared with the general population. Furthermore, analysis of a separate 22q11.2 deletion cohort suggested a 12- to 15-fold increased NTD risk of meningomyelocele. The loss of Crkl , one of several neural tube–expressed genes within the minimal deletion interval, was sufficient to replicate NTDs in mice, where both penetrance and expressivity were exacerbated by maternal folate deficiency. Thus, the common 22q11.2 deletion confers substantial meningomyelocele risk, which is partially alleviated by folate supplementation.
- Open Access
- 6 February 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (6)
Streamlined identification of clinically and functionally relevant genetic regulators of lower-tract urogenital development
Congenital anomalies of the lower genitourinary (LGU) tract are frequently comorbid due to genetically linked developmental pathways, and are among the most common yet most socially stigmatized congenital phenotypes. Genes involved in sexual differentiation are prime candidates for developmental anomalies of multiple LGU organs, but insufficient prospective screening tools have prevented the rapid identification of causative genes. Androgen signaling is among the most influential modulators of LGU development. The present study uses SpDamID technology in vivo to generate a comprehensive map of the pathways actively regulated by the androgen receptor (AR) in the genitalia in the presence of the p300 coactivator, identifying wingless/integrated (WNT) signaling as a highly enriched AR-regulated pathway in the genitalia. Transcription factor (TF) hits were then assayed for sexually dimorphic expression at two critical time points and also cross-referenced to a database of clinically relevant copy number variations to identify 252 TFs exhibiting copy variation in patients with LGU phenotypes. A subset of 54 TFs was identified for which LGU phenotypes are statistically overrepresented as a proportion of total observed phenotypes. The 252 TF hitlist was then subjected to a functional screen to identify hits whose silencing affects genital mesenchymal growth rates. Overlap of these datasets results in a refined list of 133 TFs of both functional and clinical relevance to LGU development, 31 of which are top priority candidates, including the well-documented renal progenitor regulator, Sall1. Loss of Sall1 was examined in vivo and confirmed to be a powerful regulator of LGU development.
- 6 February 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (6)
Open AccessStreamlined identification of clinically and functionally relevant genetic regulators of lower-tract urogenital development
Congenital anomalies of the lower genitourinary (LGU) tract are frequently comorbid due to genetically linked developmental pathways, and are among the most common yet most socially stigmatized congenital phenotypes. Genes involved in sexual differentiation are prime candidates for developmental anomalies of multiple LGU organs, but insufficient prospective screening tools have prevented the rapid identification of causative genes. Androgen signaling is among the most influential modulators of LGU development. The present study uses SpDamID technology in vivo to generate a comprehensive map of the pathways actively regulated by the androgen receptor (AR) in the genitalia in the presence of the p300 coactivator, identifying wingless/integrated (WNT) signaling as a highly enriched AR-regulated pathway in the genitalia. Transcription factor (TF) hits were then assayed for sexually dimorphic expression at two critical time points and also cross-referenced to a database of clinically relevant copy number variations to identify 252 TFs exhibiting copy variation in patients with LGU phenotypes. A subset of 54 TFs was identified for which LGU phenotypes are statistically overrepresented as a proportion of total observed phenotypes. The 252 TF hitlist was then subjected to a functional screen to identify hits whose silencing affects genital mesenchymal growth rates. Overlap of these datasets results in a refined list of 133 TFs of both functional and clinical relevance to LGU development, 31 of which are top priority candidates, including the well-documented renal progenitor regulator, Sall1. Loss of Sall1 was examined in vivo and confirmed to be a powerful regulator of LGU development.
- Open Access
- 28 December 2022
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (1) , pgac300
Development of an in-vitro high-throughput screening system to identify modulators of genitalia development
Sexually dimorphic outgrowth and differentiation of the embryonic genital tubercles (GTs) give rise to the penis in males and the clitoris in females. Defects in androgen production or in response to androgen signaling can lead to various congenital penile anomalies in both mice and humans. Due to lack of a high-throughput screening system, identification of crucial regulators of GT sexual differentiation has been slow. To overcome this research barrier, we isolated embryonic GT mesenchymal (GTme) cells to model genitalia growth and differentiation in vitro. Using either a mechanical or fluorescence-activated cell sorting–assisted purification method, GTme cells were isolated and assayed for their proliferation using a microscopy and image analysis system, on a single cell level over time. Male and female GTme cells inherently exhibit different cellular dynamics, consistent with their in-vivo behaviors. This system allows for the rapid quantitative analyses of numerous drug treatments, and enables the discovery of potential genetic modulators of GT morphogenesis on a large scale. Using this system, we completed a 438-compound library screen and identified 82 kinase inhibitor hits. In mice, in-utero exposure to one such candidate kinase inhibitor, Cediranib, resulted in embryos with severe genitalia defects, especially in males. Gene silencing by RNAi was optimized in this system, laying the foundation for future larger-scale genetic screenings. These findings demonstrate the power of this novel high-throughput system to rapidly and successfully identify modulators of genitalia growth and differentiation, expanding the toolbox for the study of functional genomics and environmental factors.
- 28 December 2022
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (1) , pgac300
Open AccessDevelopment of an in-vitro high-throughput screening system to identify modulators of genitalia development
Sexually dimorphic outgrowth and differentiation of the embryonic genital tubercles (GTs) give rise to the penis in males and the clitoris in females. Defects in androgen production or in response to androgen signaling can lead to various congenital penile anomalies in both mice and humans. Due to lack of a high-throughput screening system, identification of crucial regulators of GT sexual differentiation has been slow. To overcome this research barrier, we isolated embryonic GT mesenchymal (GTme) cells to model genitalia growth and differentiation in vitro. Using either a mechanical or fluorescence-activated cell sorting–assisted purification method, GTme cells were isolated and assayed for their proliferation using a microscopy and image analysis system, on a single cell level over time. Male and female GTme cells inherently exhibit different cellular dynamics, consistent with their in-vivo behaviors. This system allows for the rapid quantitative analyses of numerous drug treatments, and enables the discovery of potential genetic modulators of GT morphogenesis on a large scale. Using this system, we completed a 438-compound library screen and identified 82 kinase inhibitor hits. In mice, in-utero exposure to one such candidate kinase inhibitor, Cediranib, resulted in embryos with severe genitalia defects, especially in males. Gene silencing by RNAi was optimized in this system, laying the foundation for future larger-scale genetic screenings. These findings demonstrate the power of this novel high-throughput system to rapidly and successfully identify modulators of genitalia growth and differentiation, expanding the toolbox for the study of functional genomics and environmental factors.
- Open Access
- 8 September 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (17)
Signaling through retinoic acid receptors is essential for mammalian uterine receptivity and decidualization
Retinoic acid (RA) signaling has long been speculated to regulate embryo implantation, because many enzymes and proteins responsible for maintaining RA homeostasis and transducing RA signals are tightly regulated in the endometrium during this critical period. However, due to a lack of genetic data, it was unclear whether RA signaling is truly required for implantation and which specific RA signaling cascades are at play. Herein we utilize a genetic murine model that expresses a dominant-negative form of RA receptor (RAR) specifically in female reproductive organs to show that functional RA signaling is fundamental to female fertility, particularly implantation and decidualization. Reduction in RA signaling activity severely affects the ability of the uterus to achieve receptive status and decidualize, partially through dampening follistatin expression and downstream activin B/bone morphogenetic protein 2 signaling. To confirm translational relevance of these findings to humans, human endometrial stromal cells (hESCs) were treated with a pan-RAR antagonist to show that in vitro decidualization is impaired. RNA interference perturbation of individual RAR transcripts in hESCs revealed that RARα in particular was essential for proper decidualization. These data provide direct functional evidence that uterine RAR-mediated RA signaling was crucial for mammalian embryo implantation, and its disruption led to failure of uterine receptivity and decidualization, resulting in severely compromised fertility.
- 8 September 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (17)
Open AccessSignaling through retinoic acid receptors is essential for mammalian uterine receptivity and decidualization
Retinoic acid (RA) signaling has long been speculated to regulate embryo implantation, because many enzymes and proteins responsible for maintaining RA homeostasis and transducing RA signals are tightly regulated in the endometrium during this critical period. However, due to a lack of genetic data, it was unclear whether RA signaling is truly required for implantation and which specific RA signaling cascades are at play. Herein we utilize a genetic murine model that expresses a dominant-negative form of RA receptor (RAR) specifically in female reproductive organs to show that functional RA signaling is fundamental to female fertility, particularly implantation and decidualization. Reduction in RA signaling activity severely affects the ability of the uterus to achieve receptive status and decidualize, partially through dampening follistatin expression and downstream activin B/bone morphogenetic protein 2 signaling. To confirm translational relevance of these findings to humans, human endometrial stromal cells (hESCs) were treated with a pan-RAR antagonist to show that in vitro decidualization is impaired. RNA interference perturbation of individual RAR transcripts in hESCs revealed that RARα in particular was essential for proper decidualization. These data provide direct functional evidence that uterine RAR-mediated RA signaling was crucial for mammalian embryo implantation, and its disruption led to failure of uterine receptivity and decidualization, resulting in severely compromised fertility.
- 5 February 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (8) , 201716092-E1858
16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development
Significance: Copy number gains and losses have long been studied as the potential causes of various congenital defects. Urogenital birth defects account for as many at 30% of structural anomalies, and the 16p11.2 genetic locus is among the most common copy variant regions. Herein is shown that variation in copy number of the transcription factor MA Z , located within the 16p11.2 locus, contributes significantly to a wide range of the urogenital birth defects associated with this genomic syndrome, including structural abnormalities of the developing kidneys, ureters, and bladder. Understanding large chromosomal aberrations by studying the functions of individual developmental genes at each variant locus will pave the way for future targeted therapies in affected pregnancies.
- 5 February 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (8) , 201716092-E1858
16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development
Significance: Copy number gains and losses have long been studied as the potential causes of various congenital defects. Urogenital birth defects account for as many at 30% of structural anomalies, and the 16p11.2 genetic locus is among the most common copy variant regions. Herein is shown that variation in copy number of the transcription factor MA Z , located within the 16p11.2 locus, contributes significantly to a wide range of the urogenital birth defects associated with this genomic syndrome, including structural abnormalities of the developing kidneys, ureters, and bladder. Understanding large chromosomal aberrations by studying the functions of individual developmental genes at each variant locus will pave the way for future targeted therapies in affected pregnancies.
- Open Access
- 24 April 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (19) , 4981-4986
Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development
Significance: Common deletions affecting multiple genes that cause multiple birth defects can be studied by investigating each gene’s independent role in embryonic development. This study shows that a specific gene, CRKL, which lies within the commonly deleted region at chromosome locus 22q11.2, is required for normal overall embryonic growth, and normal development of the kidneys and testes. Deletion of only the Crkl gene in mice is sufficient to cause increased incidence of birth defects commonly seen in humans who possess deletion at 22q11.2. This study shows that CRKL is one of the key genes whose deletion contributes to the urogenital birth defects associated with multiple-gene deletion at chromosome 22q11.2, indicating a new target for gene therapy in affected patients.
- 24 April 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (19) , 4981-4986
Open AccessMurine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development
Significance: Common deletions affecting multiple genes that cause multiple birth defects can be studied by investigating each gene’s independent role in embryonic development. This study shows that a specific gene, CRKL, which lies within the commonly deleted region at chromosome locus 22q11.2, is required for normal overall embryonic growth, and normal development of the kidneys and testes. Deletion of only the Crkl gene in mice is sufficient to cause increased incidence of birth defects commonly seen in humans who possess deletion at 22q11.2. This study shows that CRKL is one of the key genes whose deletion contributes to the urogenital birth defects associated with multiple-gene deletion at chromosome 22q11.2, indicating a new target for gene therapy in affected patients.